Contact Us
Sign In / Sign Up for FREE
Go to advanced search...

Neutropenia in the chemotherapy patient - Research Paper Example

Comments (1) Cite this document
Neutropenia in the Chemotherapy Patient NAME EDUCATIONAL INSTITUTION Neutropenia is a disorder characterized by a low number of neutrophils, the most important type of white blood cell and one which serves to defend against many infections (Schwenkglenks, 2011)…
Download full paperFile format: .doc, available for editing
GRAB THE BEST PAPER92.5% of users find it useful
Neutropenia in the chemotherapy patient
Read TextPreview

Extract of sample "Neutropenia in the chemotherapy patient"

Neutropenia in the Chemotherapy Patient EDUCATIONAL Neutropenia is a disorder characterized by a low number of neutrophils, the most important type of white blood cell and one which serves to defend against many infections (Schwenkglenks, 2011). As neutrophils have a short lifespan and a very fast turnover, they can be particularly sensitive to many types of chemotherapy (Wood & Pizzo, 1993), meaning that patients undergoing cancer treatment often present with neutropenia and the related symptoms (Kuderer et al, 2007). The concerns that come from this are numerous. Firstly, chemotherapy is a stressful time for the human body, and therefore any further weakening such as neutropenia can cause severe distress and further illness to the patient (Schwenkglenks, 2011). Secondly, as the primary role of neutrophils is to prevent against infection and cancer patients have multiple and frequent contact with the hospital environment, they become immediately more susceptible to any infections found within the hospital, some of which are antibiotic resistant (Kuderer et al, 2007). Finally, any problems arising from neutropenia can disrupt the dosages of chemotherapeutic drugs and therefore delay treatment, causing further problems with cancer (Wood & Pizzo, 1993). Evidently, one of the main goals of cancer treatment is to try to ensure that the patient is as healthy as possible throughout the treatment, and therefore the problem of neutropenia in the chemotherapy patient should be addressed to try and reduce incidences of the problem as well as complications that may arise from the disorder. It is interesting that patients with neutropenia often experience delays in their chemotherapy treatment, again highlighting the need to reduce or eradicate cases of neutropenia. Any delay in chemotherapy can cause the cancer to become more aggressive and even lead to it being in a fatal stage (Schwenkglenks, 2011), so any delay in treatment needs to be avoided as far as possible. However, a paatient with neutropenia or a neutopenia-related infection cannot always carry on with chemotherapeutic treatment and therefore may experience delays, so aiming to reduce the incidence of neutropenia in the chemotherapy patient could lower the number of deaths from cancer. To utilize PICO, the summary of the problems with this disease is as follows: Patient – those currently receiving chemotherapy treatment suffering from neutropenia Intervention – giving information and education to both patients and clinical staff about the dangers, risks and avoidance of neutropenia Comparison – compare the frequency and complications of neutropenia following this intervention to the current state of affairs Outcome – the proposed outcome is that there will be a decrease in chemotherapy patients with neutropenia and the related complications. The proposed change here, then, is the education of patients and staff members about how to avoid neutropenia in the chemotherapy patient. This could be established with education about the types of chemotherapy which are least associated with causing neutropenia (Schwenkglenks, 2011), information about recognizing the symptoms of neutropenia to allow for swift treatment and recovery prior to a life-threatening infection, and providing guidance on neutropenia protocol. This information could be supplied in a number of ways and should be easily accessible to allow for both patient and staff training on neutropenia. It should be delivery before, during and after chemotherapy for maximum benefit. Obviously the benefits of this are numerous. It could help reduce the incidence of neutropenia in the chemotherapy patient, allowing for more effective cancer treatment and avoidance of life-threatening infections from the low neutrophil count (Crawford et al, 1991). All patients with cancer hope for a swift and healthy recovery, so avoiding neutropenia in the health community would allow an element of relief for these patients who are already suffering from a deadly disease and wish to avoid complications (Wood & Pizzo, 1993). It would also allow healthcare staff to spot the signs of neutropenia before they develop into infectious diseases, preventing complications further, again giving the patient a degree of relief. It should be recognized that simply educating people will not prevent neutropenia in the chemotherapy patient will not eradicate the problem, it should help lower the number of cases and complications, which is something that should not be underestimated. Works Cited Crawford, J., Ozer, H., Stoller, R., Johnson, D., Lyman, G., Tabbara, I., Kris, M., et al. (1991). Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. New England Journal of Medicine, 325(3), 164–170. Kuderer, N. M., Dale, D. C., Crawford, J., & Lyman, G. H. (2007). Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. Journal of clinical oncology, 25(21), 3158. Schwenkglenks, M., Pettengell, R., Jackisch, C., Paridaens, R., Constenla, M., Bosly, A., Szucs, T. D., et al. (2011). Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study. Supportive Care in Cancer, 19(4), 483–490. Wood, A. J. J., & Pizzo, P. A. (1993). Management of fever in patients with cancer and treatment-induced neutropenia. New England Journal of Medicine, 328(18), 1323–1332. Read More
Cite this document
  • APA
  • MLA
(“Neutropenia in the chemotherapy patient Research Paper”, n.d.)
Retrieved from
(Neutropenia in the Chemotherapy Patient Research Paper)
“Neutropenia in the Chemotherapy Patient Research Paper”, n.d.
  • Cited: 0 times
Comments (1)
Click to create a comment or rate a document
schuppebradley added comment 11 days ago
Student rated this paper as
Good paper! Used it to finish an assignment for a nursing course. It was easy as ABC, for the first time in my life.

CHECK THESE SAMPLES OF Neutropenia in the chemotherapy patient

Neutropenia in the Chemotherapy Patient

...? Decreasing Rates of Neutropenia in the Chemotherapy Patient School Number and Session Decreasing Rates of Neutropenia in the Chemotherapy Patient Literature Review A review of the literature suggests that 'not only a life-threatening complication, it can also lead to a decision to reduce chemotherapy intensity in subsequent treatment cycles' (Cameron, 2009, p101), suggesting that it is important to understand the condition, how it arises and methods that can be used to lower the rate of neutropenia in the chemotherapy patient. A survey found that only half of hospitals...
4 Pages(1000 words)Essay

Chemotherapy: High-Risk Complications

...anti-inflammatory drugs. Checking the patient for signs and symptoms of excess or deficit fluid volume and drug toxicity is also important. Febrile Neutropenia Febrile neutropenia is the most potential high risk complication of chemotherapy because this condition may cause even stable patients to develop hemodynamic instability and critical illness. The victim may die unless prompt monitoring and interventions are conducted. As Bolyard., Cottle., Edwards., Kinsey., Schwinzer & Zeidler (n.d) point out, neutropenia is diagnosed when the patient’s absolute neutrophil count falls below 500 cells/mm3. In...
4 Pages(1000 words)Research Paper

Cancer Chemotherapy

... without undergoing cell death," says Jack Pinski, M.D., Ph.D., assistant professor of medical oncology at USC/Norris. "Only a small percentage of cancer cells are proliferating at a time. In order for chemotherapy to be effective, it has to kill the cells while they are multiplying and dividing in the cell cycle." As well, Pack points out that some cancer cells develop a resistance to particular chemotherapeutic agents over time, decreasing their effectiveness on the disease. Chemotherapeutic agents must be tailored to an individual's cancer type because different tumors respond to different therapies. Even patients diagnosed with the same disease may require different drug combinations for treatment, Neamati says... . A...
14 Pages(3500 words)Essay

Care for a Patient undergoing Chemotherapy

...retention as evidenced by peripheral edema and weight gain. Gastrointestinal: nausea, vomiting, diarrhea, stomatitis Skin: alopecia General: hypersensitivity reactions Life-threatening Adverse Reactions Hematologic: neutropenia, leucopenia, thrombocytopenia, anemia Critical Analysis of Care For patients with advanced breast cancer who are not suitable for anthracyclines (because they are contraindicated or because of prior anthracycline treatment either in the adjuvant or metastatic setting), systemic chemotherapy should be offered, where single-agent docetaxel is the first line drug. (NICE, 2008, p.10) ___ Table 2. TRASTUZUMAB Generic Name Trastuzumab Brand...
20 Pages(5000 words)Case Study

Communication in Chemotherapy

...IS THE WAY IN WHICH WE COMMUNICATE INFORMTION TO CHEMOTHERAPY PATIENTS EFFECTIVE Word Count 9,441 IS THE WAY IN WHICH WE COMMUNICATE INFORMATION TO CHEMOTHERAPY PATIENTS EFFECTIVE TABLE OF CONTENTS I. Abstract II. Introduction A. Reason for Study B. Aim of Dissertation III. Critical Review of the Literature A. What they want to know B. When to give the information C. Patient Outcomes D. Provider Education E. Discussion 1. Questions that need to be addressed IV . Proposal A. Introduction/ Background B. Rational C. Aim C. Research approach/ Method D. Timetable E. Personnel F. Budget E. Summary/ General...
23 Pages(5750 words)Essay

Cytotoxic Chemotherapy

...Introduction to Cytotoxic Chemotherapy: A Reflective Essay Introduction: This is a reflective essay about a patient whose identity is has been intentionally kept undisclosed for ethical reasons and for reasons of confidentiality. The patient is a 40-year-old single female who was taken care of in the clinical practice. This patient had stage 1 carcinoma of the breast with no lymph node involvement at presentation. The patient underwent FEC chemotherapy for this. The chemotherapy was uneventful except for some nausea that was managed well with antiemetic medications. This reflective essay is a journey through the cytotoxic...
12 Pages(3000 words)Essay

Care of the patient having Cytotoxic Chemotherapy (GM50Z8)

...A Patient’s Guide to Chemotherapy: A Critique Patient Information Leaflets (PILs) are very essential in a patient’s life. Patients are advised to know what kind of treatment they are taking or in what condition they are now experiencing. It is a must that they know it by heart. It is their health, so to speak and it is their life. They have all the right to know everything. That is why there are consultations with the doctor. However, according to Wilson [1998], a study showed that patients forget half the doctor’s advise after five minutes they have left the consultation room. This is quite an alarming state. To think that...
12 Pages(3000 words)Essay

Neutropenia in the chemotherapy patient

...References Chabner, B., Lynch, T. J., & Longo, D. L. (2008). Harrisons manual of oncology . New York: McGraw-Hill Medical. This manual is written togive details on the vast amount of clinical information given to those administrating cancer care. The manual gives information on the medications given to those with cancer as well as information on the side-effects that these may have. The provision of information about side-effects gave a lot of information about which medications cause neutropenia in chemotherapy patients and why, which was relevant to this paper. The reliability of this source was high, because it has been published in many editions and is recommended by several clinicians. Friese, C. (2006). Chemotherapy-induced... ...
3 Pages(750 words)Annotated Bibliography

Decreasing Rates of Neutropenia in the Chemotherapy Patient

...Decreasing Rates of Neutropenia in the Chemotherapy Patient EDUCATIONAL Decreasing Rates of Neutropenia in the Chemotherapy PatientNeutropenia is a disease characterized by a low neutrophil count, which can be caused in a variety of ways. Certain medication can cause a low neutrophil count, especially those used for chemotherapy in cancer patients (Deinard et al, 1974). The primary concern for these patients is that neutropenia often means that chemotherapy treatment must be halted to prevent any further problems, and this delay may...
2 Pages(500 words)Research Paper

Chemotherapy Lounge

...Chemotherapy Lounge Question The ingenious uses a number of metaphors to portray what patients often expect and what nurses offer to their patients. The poem asserts that nurses are less compassionate since they simply administer drugs to patients and walk away leaving their patients to conjure the pain on their own. At some instance, the nurse wears a Halloween uniform in the poem a metaphor that portrays the nurse trying to disguise his identity. I felt remorseful for nurses since the poem misrepresents their roles. I understand that not every patient is always less compassionate. The fact that they attend to hundreds of patients in a day requires them to focus on their work and may always portray them as less compassionate... . ...
1 Pages(250 words)Assignment
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.

Let us find you another Research Paper on topic Neutropenia in the chemotherapy patient for FREE!

Contact Us